Postdoctoral Scholar
Stanford University School of Medicine
Kwang Bog Cho, PhD, is a postdoctoral researcher in Dr. Michael Lim's laboratory at Stanford University Department of Neurosurgery. Her research focuses on neuroinflammation in mouse models of traumatic brain injury (TBI) and local chemotherapy with anti-PD-1 in glioma models.
Having earned her PhD in Pharmacological and Pharmaceutical Sciences from the University of Houston (2021), Dr. Cho investigates complex immune responses driving secondary brain injury after severe TBI (sTBI). She studies soluble PD-L1 therapy to modulate PD-1/PD-L1 signaling in monocytes, reducing neuroinflammatory responses. Utilizing blood, bone marrow, and brain tissue samples, she evaluates inflammatory responses in classical monocytes following sPD-L1 treatment. This strategy reprograms pro-inflammatory M1-like monocytes toward anti-inflammatory M2-like phenotypes, reducing pro-inflammatory cytokine production and promoting anti-inflammatory responses.
During her PhD, she established arthritis/inflammatory disease mouse models to validate novel compounds identified through on-bead two-color (OBTC) screening. Her postdoctoral research extends this expertise to sTBI neuroinflammation and glioma immunotherapy.
Disclosure(s): No financial relationships to disclose
Saturday, May 2, 2026
2:45 PM - 3:30 PM CT